Neurologists trust a simple at-home dementia test which needs just a pen, paper and timer as a early screening tool. Dr Eric ...

We were surprised to see the effect only in the Alzheimer’s spectrum and not in other neurodegenerative diseases." The post ...

Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, ...

Unlike expensive positron emission tomography (PET) scans or invasive lumbar punctures, the new blood test measures the ratio of two proteins, pTau217 and ß-Amyloid 1-42, which are implicated in ...

Dr. Ausim Azizi is among those seeing the overall early results, as Yale New Haven Hospital is in the forefront of research ...

A pen, paper, and 30 seconds might be all it takes to uncover if you are struggling with early dementia signs, as Fiona ...

Sometimes, when people talk about dementia screenings, they are referring to just the cognitive testing portion of this assessment, and other times, they are referring to the entire group of tests.

Bottom line: While there may not be a “dementia test” your doctor can give you, cognitive screening tests are the next best thing. They can help your doctor determine whether your symptoms are ...

A new study has found that a simple blood test may be a powerful way to detect early signs of Alzheimer’s disease, even in ...

Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

The test can be done at home and only requires a pen and paper to complete, and something to keep track of your time limit.

Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in ...